| 6.64 -0.46 (-6.48%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.68 | 1-year : | 14.81 |
| Resists | First : | 10.85 | Second : | 12.68 |
| Pivot price | 4.78  |
|||
| Supports | First : | 4.78 | Second : | 1.02 |
| MAs | MA(5) : | 6.39 |
MA(20) : | 4.2 |
| MA(100) : | 4.09 |
MA(250) : | 9.15 |
|
| MACD | MACD : | 1 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 58 |
D(3) : | 64.4 |
| RSI | RSI(14): 64.8 |
|||
| 52-week | High : | 32.09 | Low : | 1.02 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AGPU ] has closed below upper band by 19.2%. Bollinger Bands are 132.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.26 - 7.3 | 7.3 - 7.33 |
| Low: | 6.44 - 6.49 | 6.49 - 6.52 |
| Close: | 6.57 - 6.64 | 6.64 - 6.7 |
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Fri, 24 Apr 2026
AGPU stock surges 90%, breaks 200-DMA for first time in over six months – what’s driving this super rally? - MSN
Thu, 23 Apr 2026
Axe Compute’s $260 Million GPU Deal Sends Stock Soaring More Than 80% - Yahoo Finance
Thu, 23 Apr 2026
Axe Compute Secures Record $260 Million AI Infrastructure Deal - The Globe and Mail
Wed, 22 Apr 2026
Axe Compute Soars on $260M Nvidia Deal. Is It Too Late to Buy AGPU Stock? - Barchart.com
Wed, 22 Apr 2026
Axe Compute jumps nearly 96% after unveiling a $260M enterprise NVIDIA B300 GPU deal - Quiver Quantitative
Wed, 22 Apr 2026
Axe Compute Stock Doubles After Securing $260M AI Infrastructure Deal - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | 0 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 3.96e+006 (%) |
| Held by Institutions | 13.5 (%) |
| Shares Short | 140 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.83e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -232 % |
| Return on Assets (ttm) | 861.2 % |
| Return on Equity (ttm) | -61.5 % |
| Qtrly Rev. Growth | 125280 % |
| Gross Profit (p.s.) | -0.91 |
| Sales Per Share | -680.66 |
| EBITDA (p.s.) | 36569.4 |
| Qtrly Earnings Growth | -13.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0.81 |
| Dividend | 0 |
| Forward Dividend | 168160 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|